Last reviewed · How we verify

NCT06869031

Adaptive Intervention Model for Hypertension Self-Management in Rural Areas: A Doctor-Patient Interaction Approach

Recruiting now NA Last updated 20 August 2025
What this trial tests

NA trial testing Standard Interactive Intervention for Hypertension Management in Hypertension Self-management in 320 participants. Currently enrolling.

Timeline
1 June 2025
Primary endpoint
15 June 2026
31 December 2026

Quick facts

Lead sponsorYuju Wu
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designsequential
Maskingnone
Primary purposeprevention
Enrollment320
Start date1 June 2025
Primary completion15 June 2026
Estimated completion31 December 2026
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Yuju Wu

Who can join

Adults 18 to 80, any sex, with Hypertension Self-management or Hypertension. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this project is to develop and validate an adaptive intervention model to improve self-management behavior in rural hypertensive patients. The primary question it seeks to answer is: Can a tailored, interaction-based intervention model, guided by key doctor-patient interaction elements, effectively enhance self-management behavior among rural hypertensive patients and improve long-term blood pressure control? Researchers will evaluate the impact of different intervention strategies on self-management behavior and identify the most effective combination to establish a sustainable intervention model for rural hypertension management.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Adaptive intervention to improve self-management behaviours among hypertensive patients in rural primary care settings: protocol for a Sequential Multiple Assignment Randomised Trial (SMART).
    Xian X, Zhao T, Du S, Zhang H, et al · · 2026 · PMID 41857823 · DOI 10.1136/bmjopen-2025-109445

Verify or expand the search:

Other Yuju Wu trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06869031.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing